Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer

Xiu-ying Li,Luan-xia Shi,Xue-min Yao,Ming Jing,Qin-qing Li,Ying-li Wang,Qing-shan Li

DOI: https://doi.org/10.1080/03639045.2020.1862169

IF: 3.727

2021-01-02

Drug Development and Industrial Pharmacy

Abstract:<span>Gastric cancer is one of the leading causes of cancer-related death worldwide with a poor prognosis. Gastric cancer is usually treated with surgery and chemotherapy, accompanied by a high rate of metastasis and recurrence. In this paper, R₈ (RRRRRRRR) modified vinorelbine plus schisandrin B liposomes had been successfully constructed for treating gastric cancer. In the liposomes, R₈ was used to enhance the intracellular uptake, schisandrin B was incorporated into liposomes for inhibiting tumor cells metastasis, and vinorelbine was encapsulated into liposomes as antitumor drugs. Studies were performed on BGC-823 cells <i>in vitro</i> and were verified in the BGC-823 cell xenografts nude mice <i>in vivo</i>. Results <i>in vitro</i> demonstrated that the targeting liposomes could induce BGC-823 cells apoptosis, inhibit the metastasis of tumor cells, and increase targeting effects to tumor cells. Meanwhile, action mechanism studies showed that the targeting liposomes could down-regulate VEGF, VE-Cad, HIF-1a, PI3K, MMP-2, and FAK to inhibit tumor metastasis. <i>In vivo</i> results exhibited that the targeting liposomes displayed an obvious antitumor efficacy by accumulating selectively in tumor site and induce tumor cell apoptosis. Hence, R₈ modified vinorelbine plus schisandrin B liposomes might provide a safe and efficient therapy strategy for gastric cancer.</span>

pharmacology & pharmacy,chemistry, medicinal